Inventor · disambiguated record
Michael Buschle
Also filed as: BUSCHLE MICHAEL
12 granted patents·20 pending applications·276 citations·filing 1995–2014
92Inventor score
Files withINTERCELL AG12BUSCHLE MICHAEL6CISTEM BIOTECHNOLOGIES GMBH4BOEHRINGER INGELHEIM INT2FLEITMANN JULIA-KRISTINA1
Top patents by PatentIndex Score
32 records- 0192US7148191B2Antigenic compositionINTERCELL AG·Filed 2001·Granted Dec 12, 2006·58 cites·22 claims
- 0291US6869607B1Vaccine formulationsINTERCELL AG·Filed 1999·Granted Mar 22, 2005·110 cites·28 claims
- 0387US7658928B2Method of vaccination comprising administering an antigen and a cathelicidin derived antimicrobial peptideINTERCELL AG·Filed 2007·Granted Feb 9, 2010·6 cites·6 claims
- 0486US8784837B2Vaccines comprising an immunostimulatory peptide and an immunostimulatory oligodeoxynucleic acid moleculeBUSCHLE MICHAEL·Filed 2010·Granted Jul 22, 2014·7 cites·18 claims
- 0582US7704514B2VaccinesINTERCELL AG·Filed 2004·Granted Apr 27, 2010·14 cites·9 claims
- 0682US7244438B2Uses for polycationic compoundsINTERCELL AG·Filed 2002·Granted Jul 17, 2007·11 cites·4 claims
- 0775US7378234B2Method for isolating hepatitis C virus peptidesINTERCELL AG·Filed 2003·Granted May 27, 2008·11 cites·31 claims
- 0871US8277815B2Pharmaceutical composition comprising an antigenBUSCHLE MICHAEL·Filed 2011·Granted Oct 2, 2012·3 cites·14 claims
- 0970US8361476B2Vaccine composition comprising an antigen and a peptide having adjuvant propertiesINTERCELL AG·Filed 2001·Granted Jan 29, 2013·4 cites·5 claims
- 1070US5965404AMethod for introducing nucleic acids into higher eukaryotic cellsBOEHRINGER INGELHEIM INT·Filed 1995·Granted Oct 12, 1999·27 cites·49 claims
- 1167US8900564B2Vaccine composition comprising an antigen and a peptide having adjuvant propertiesFritz Jörg·Filed 2008·Granted Dec 2, 2014·1 cites·15 claims
- 1265US2008025996A1Methods and Compositions Comprising Polycationic CompoundsLINGNAU KAREN·Filed 2007·Application pending·0 cites
- 1364US7105162B1Pharmaceutical composition for immunomodulation based on peptides and adjuvantsBOEHRINGER INGELHEIM INT·Filed 1997·Granted Sep 12, 2006·24 cites·32 claims
- 1463US2007218073A1Antigenic compositionINTERCELL AG·Filed 2006·Application pending·0 cites
- 1557US2009155294A1Hcv vaccinesBUSCHLE MICHAEL·Filed 2008·Application pending·0 cites
- 1656US2009130135A1Hcv vaccinesBUSCHLE MICHAEL·Filed 2008·Application pending·0 cites
- 1755US2015010595A1Vaccines comprising an immunostimulatory peptide and an immunostimulatory oligodeoxynucleic acid moleculeVALNEVA AUSTRIA GMBH·Filed 2014·Application pending·0 cites
- 1855US2009060875A1HCV Vaccines for Chronic HCV PatientsINTERCELL AG·Filed 2005·Application pending·0 cites
- 1954US2009104217A1Pharmaceutical Composition Comprising An AntigenFLEITMANN JULIA-KRISTINA·Filed 2008·Application pending·0 cites
- 2053US2013216583A1Vaccine composition comprising an antigen and a peptide having adjuvant propertiesINTERCELL AG·Filed 2013·Application pending·0 cites
- 2153US2007041998A1Use of alum and a th1 immune response inducing adjuvant for enhancing immune responsesINTERCELL AG·Filed 2004·Application pending·0 cites
- 2253US2007031446A1Hcv vaccinesINTERCELL AG·Filed 2004·Application pending·0 cites
- 2351US2009081246A1Method for isolating hepatitis c virus peptidesBUSCHLE MICHAEL·Filed 2008·Application pending·0 cites
- 2451US2004170642A1Vaccine which comprises at least one antigen and a cathelididin derived antimicrobial peptide of a derivative thereofFiled 2001·Application pending·0 cites
- 2550US2003095979A1Pharmaceutical preparations comprising modified peptidesCISTEM BIOTECHNOLOGIES GMBH·Filed 2002·Application pending·0 cites
- 2646US2005163797A1Pharmaceutical composition comprising an antigenCISTEM BIOTECHNOLOGIES GMBH·Filed 2005·Application pending·0 cites
- 2745US2011300170A1Hcv vaccinesBUSCHLE MICHAEL·Filed 2011·Application pending·0 cites
- 2843US2010322972A1HCV Vaccines For Chronic HCV PatientsFRISCH JUERGEN·Filed 2010·Application pending·0 cites
- 2942US2003099663A1Pharmaceutical composition comprising an antigenCISTEM BIOTECHNOLOGIES GMBH·Filed 2002·Application pending·0 cites
- 3041US2002197269A1Pharmaceutical composition for immunomodulation and preparation of vaccinesCISTEM BIOTECHNOLOGIES GMBH·Filed 2002·Application pending·0 cites
- 3139US2004081655A1Methods and compositions comprising polycationic compoundsFiled 2002·Application pending·0 cites
- 3225US2002085997A1Tumour vaccine and process for the preparation thereofFiled 1996·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →